Zeao pharmaceutical hydrochloric acid Jacktinib tablets approved clinical treatment of moderate and severe adhesion dermatitis

Acacid Jacktinib is the company's independent research and development of small moleculeJAK kinase inhibitors new drugs, can block JAK kinase / signal transduction and transcription activation factor (STAT) JAK-STAT signal conduction pathway, thereby improving immune-related inflammatory effectsInsight database shows that three JAK inhibitors have been approved in ChinaOf these, only tofate cloths have been approved for generic drugsimage source: Insight Database (https://db.dxy.cn/)It's worth noting that Hengrui's new class 1 drug, SHR0302, is also a JAK inhibitor and is currently being used in phase 2 clinical recruitment for myopic dermatitisZea-yin pharmaceutical hydrochloric acid Jacktinib tablets have been approved psoriasis, idiopathic pulmonary fibrosis, strong scoliosis, rheumatoid arthritis, severe spotting and asexual dermatitis and other indications;Image Source: Insight Database (https://db.dxy.cn/)original title: Zeayu Pharmaceuticals Class 1 new drug "Jacktinib Tablets hydrochloric acid" approved for clinical treatment of moderate and severe asexual dermatitis